Skip to main content

Advertisement

Log in

Pregnancy and neonatal outcomes of artificial oocyte activation in patients undergoing frozen–thawed embryo transfer: a 6-year population-based retrospective study

  • Gynecologic Endocrinology and Reproductive Medicine
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the impact of artificial oocyte activation (AOA) in pregnancy and neonatal outcomes in infertile patients undergoing cryopreserved embryo transfer.

Method

This retrospective study included 5686 patients’ transferred embryos from routine intracytoplasmic sperm injection (ICSI) and 194 patients’ transferred embryos from ICSI combined with AOA (ICSI-AOA) from January 2011 to December 2016. Pregnancy and neonatal outcomes of couples undergoing routine ICSI or ICSI-AOA were analyzed before and after propensity score matching. Artificial oocyte activation was performed with ionomycin.

Results

The pregnancy outcomes showed no significant difference in the rates of biochemical pregnancy, clinical pregnancy, implantation, miscarriage, ectopic pregnancy, multiple pregnancy, and live births between the routine ICSI and ICSI-AOA groups before and after propensity score matching, respectively. The assessment of neonatal outcomes showed no statistically significant differences in the birth defect rate, birth weight, gestational age, preterm birth rate, early-neonatal death rate, and fetal sex ratio between the two groups, and similar results were also observed in the two matched cohorts.

Conclusion

Artificial oocyte activation with ionomycin does not adversely affect pregnancy and neonatal outcomes in patients undergoing frozen–thawed embryo transfer, which is beneficial to clinicians counseling patients on the risks of artificial oocyte activation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kashir J, Heindryckx B, Jones C, de Sutter P, Parrington J, Coward K (2010) Oocyte activation, phospholipase C zeta and human infertility. Hum Reprod Update 16:690–703

    Article  CAS  PubMed  Google Scholar 

  2. Baltaci V, Ayvaz OU, Unsal E, Aktaş Y, Baltaci A, Turhan F et al (2010) The effectiveness of intracytoplasmic sperm injection combined with piezoelectric stimulation in infertile couples with total fertilization failure. Fertil Steril 94:900–904

    Article  PubMed  Google Scholar 

  3. Kyono K, Takisawa T, Nakajo Y, Doshida M, Toya M (2012) Birth and follow-up of babies born following ICSI with oocyte activation using strontium chloride or calcium ionophore A23187. J Mamm Ova Res 29:35–40

    Article  Google Scholar 

  4. Montag M, Köster M, van der Ven K, Bohlen U, van der Ven H (2012) The benefit of artificial oocyte activation is dependent on the fertilization rate in a previous treatment cycle. Reprod Biomed Online 24:521–526

    Article  PubMed  Google Scholar 

  5. Yoon HJ, Bae IH, Kim HJ, Jang JM, Hur YS, Kim HK et al (2013) Analysis of clinical outcomes with respect to spermatozoan origin after artificial oocyte activation with a calcium ionophore. J Assist Reprod Genet 30:1569–1575

    Article  PubMed  PubMed Central  Google Scholar 

  6. Ebner T, Montag M, Montag M, Van der Ven K, Van der Ven H et al (2015) Live birth after artificial oocyte activation using a ready-to-use ionophore: a prospective multicentre study. Reprod Biomed Online 30:359–365

    Article  CAS  PubMed  Google Scholar 

  7. Ebner T, Oppelt P, Wöber M, Staples P, Mayer RB, Sonnleitner U et al (2015) Treatment with Ca2+ ionophore improves embryo development and outcome in cases with previous developmental problems: a prospective multicenter study. Hum Reprod 30:97–102

    Article  CAS  PubMed  Google Scholar 

  8. Mansour R, Fahmy I, Tawab NA, Kamal A, El-Demery Y, Aboulghar M et al (2009) Electrical activation of oocytes after intracytoplasmic sperm injection: a controlled randomized study. Fertil Steril 91:133–139

    Article  PubMed  Google Scholar 

  9. Borges E, de Almeida Ferreira Braga DP, de Sousa Bonetti TC, Iaconelli A, Franco JG (2009) Artificial oocyte activation with calcium ionophore A23187 in intracytoplasmic sperm injection cycles using surgically retrieved spermatozoa. Fertil Steril 92:131–136

  10. Kang HJ, Lee SH, Park YS, Lim CK, Ko DS, Yang KM et al (2015) Artificial oocyte activation in intracytoplasmic sperm injection cycles using testicular sperm in human in vitro fertilization. Clin Exp Reprod Med 42:45–50

    Article  PubMed  PubMed Central  Google Scholar 

  11. Deemeh MR, Tavalaee M, Nasr-Esfahani MH (2015) Health of children born through artificial oocyte activation: a pilot study. Reprod Sci 22:322–328

    Article  CAS  PubMed  Google Scholar 

  12. Borges E, de Almeida Ferreira Braga DP, de Sousa Bonetti TC, Iaconelli A, Franco JG (2009) Artificial oocyte activation using calcium ionophore in ICSI cycles with spermatozoa from different sources. Reprod Biomed Online 18:45–52

    Article  CAS  PubMed  Google Scholar 

  13. Ebner T, Köster M, Shebl O, Moser M, Van der Ven H, Tews G et al (2012) Application of a ready-to-use calcium ionophore increases rates of fertilization and pregnancy in severe male factor infertility. Fertil Steril 98:1432–1437

    Article  CAS  PubMed  Google Scholar 

  14. Du T, Wang Y, Fan Y, Zhang S, Yan Z, Yu W et al (2018) Fertility and neonatal outcomes of embryos achieving blastulation on Day 7: are they of clinical value? Hum Reprod 33:1038–1051

    Article  PubMed  Google Scholar 

  15. Kuang Y, Hong Q, Chen Q, Lyu Q, Ai A, Fu Y et al (2014) Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen–thawed embryo transfer cycles. Fertil Steril 101:105–111

    Article  CAS  PubMed  Google Scholar 

  16. Chen H, Wang Y, Lyu Q, Ai A, Fu Y, Tian H et al (2015) Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles. Fertil Steril 103:1194–1201

    Article  CAS  PubMed  Google Scholar 

  17. Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology (2011) The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod 26:1270–1283

  18. Gardner DK, Schoolcraft WB (1999) In vitro culture of human blastocysts. In: Jansen R, Mortimer D (eds) Toward reproductive certainty: fertility and genetics beyond 1999. Parthenon Publishing, London, pp 378–388

    Google Scholar 

  19. Montjean D, Pauly V, Gervoise-Boyer M, Amar-Hoffet A, Geoffroy-Siraudin C, Boyer P (2019) Is it worth it to cryopreserve embryos with blastulation delay at day 5? Zygote 28:1–6

    Google Scholar 

  20. Nasr-Esfahani MH, Razavi S, Javdan Z, Tavalaee M (2008) Artificial oocyte activation in severe teratozoospermia undergoing intracytoplasmic sperm injection. Fertil Steril 90:2231–2237

    Article  PubMed  Google Scholar 

  21. Zegers-Hochschild F, Adamson GD, de Mouzon J, Ishihara O, Mansour R, Nygren K et al (2009) International committee for monitoring assisted reproductive technology (ICMART) and the world health organization (WHO) revised glossary of ART terminology, 2009. Fertil Steril 92:1520–1524

    Article  CAS  PubMed  Google Scholar 

  22. Zhu Q, Wang N, Wang B, Wang Y, Kuang Y (2018) The risk of birth defects among children born after vitrified blastocyst transfers and those born after fresh and vitrified cleavage-stage embryo transfers. Arch Gynecol Obstet 298:833–840

    Article  PubMed  Google Scholar 

  23. Zhu J, Zhu Q, Wang Y, Wang B, Lyu Q, Kuang Y (2019) Comparative study on risk for birth defects among infants after in vitro fertilization and intracytoplasmic sperm injection. Syst Biol Reprod Med 65:54–60

    Article  CAS  PubMed  Google Scholar 

  24. World Health Organization. International statistical classification of diseases and related health problems. Available at: https://apps.who.int/iris/bitstream/10665/61362/1/WHO_MNH_MEP_87.1_REV.2.pdf. Last accessed 17 March 2015

  25. Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C, Thomas S (2011) Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen–thawed embryo transfer in normal responders. Fertil Steril 96:344–348

    Article  PubMed  Google Scholar 

  26. Cobo A, de los Santos MJ, Castello D, Gamiz P, Campos P, Remohí J (2012) Outcomes of vitrified early cleavage-stage and blastocyst-stage embryos in a cryopreservation program: evaluation of 3150 warming cycles. Fertil Steril 98:1138–1146

    Article  Google Scholar 

  27. Wong KM, van Wely M, Mol F, Repping S, Mastenbroek S (2017) Fresh versus frozen embryo transfers in assisted reproduction. Cochrane Database Syst Rev 28(CD011184):27

    Google Scholar 

  28. Chen ZJ, Shi Y, Sun Y, Zhang B, Liang X, Cao Y et al (2016) Fresh versus frozen embryos for infertility in the polycystic ovary syndrome. N Engl J Med 375:523–533

    Article  PubMed  Google Scholar 

  29. Miller N, Biron-Shental T, Sukenik-Halevy R, Klement AH, Sharony R, Berkovitz A (2016) Oocyte activation by calcium ionophore and congenital birth defects: a retrospective cohort study. Fertil Steril 106:590–596

    Article  CAS  PubMed  Google Scholar 

  30. Wen J, Jiang J, Ding C, Dai J, Liu Y, Xia Y et al (2012) Birth defects in children conceived by in vitro fertilization and intracytoplasmic sperm injection: a meta-analysis. Fertil Steril 97:1331–1337

    Article  PubMed  Google Scholar 

  31. Ooki S (2015) Birth defects after assisted reproductive technology according to the method of treatment in Japan: nationwide data between 2004 and 2012. Environ Health Prev Med 20:460–465

    Article  PubMed  PubMed Central  Google Scholar 

  32. Wang N, Lin J, Zhu Q, Fan Y, Wang Y, Fu Y et al (2018) Comparison of neonatal outcomes and live-birth defects after progestin-primed ovarian stimulation versus conventional ovarian stimulation for in vitro fertilization: a large retrospective cohort study. Medicine (Baltimore) 97:e11906

    Article  CAS  Google Scholar 

  33. Samadirad B, Khamnian Z, Hosseini MB, Dastgiri S (2012) Congenital anomalies and termination of pregnancy in Iran. J Pregnancy 2012:574513

    Article  PubMed  PubMed Central  Google Scholar 

  34. Deng C, Yi L, Mu Y, Zhu J, Qin Y, Fan X, Wang Y, Li Q (2015) Dai L Recent trends in the birth prevalence of down syndrome in China: impact of prenatal diagnosis and subsequent terminations. Prenat Diagn 35(4):311–318

    Article  PubMed  Google Scholar 

  35. Hollier LM, Leveno KJ, Kelly MA, Mcintire DD, Cunningham FG (2000) Maternal age and malformations in singleton births. Obstet Gynecol 96:701–706

    CAS  PubMed  Google Scholar 

  36. Nasr-Esfahani MH, Deemeh MR, Tavalaee M (2010) Artificial oocyte activation and intracytoplasmic sperm injection. Fertil Steril 94:520–526

    Article  PubMed  Google Scholar 

  37. Nikiforaki D, Vanden Meerschaut F, de Roo C, Lu Y, Ferrer-Buitrago M, de Sutter P et al (2016) Effect of two assisted oocyte activation protocols used to overcome fertilization failure on the activation potential and calcium releasing pattern. Fertil Steril 105:798–806

    Article  CAS  PubMed  Google Scholar 

  38. Isachenko E, Isachenko V, Todorov P, Ostashko V, Kreienberg R, Kaufmann M et al (2010) Pregnancy after the calcium ionophore correction of pronuclei position in oocytes after intracytoplasmic sperm injection. Fertil Steril 94(2770):e3–5

    Google Scholar 

  39. Whittaker W, Anselmi L, Kristensen SR, Lau YS, Bailey S, Bower P et al (2016) Associations between extending access to primary care and emergency department visits: a difference-in-differences analysis. PLoS Med 13:e1002113

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank Meiping Sheng and Suqun Zhang for following up with the patients and auditing the data.

Funding

This work was supported by The National Nature Science Foundation of China (Grant Numbers 81771649 and 81571486).

Author information

Authors and Affiliations

Authors

Contributions

ZY and QL were involved in the conception and design, and revision of the article. BL, YZ, and ZY analyzed the data and completed the manuscript writing. SX, YW, RC, YF, QH, ML, and YK completed the collection of clinical data. TD, HL, and MY conducted the statistical analysis.

Corresponding authors

Correspondence to Zheng Yan or Qifeng Lyu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, B., Zhou, Y., Yan, Z. et al. Pregnancy and neonatal outcomes of artificial oocyte activation in patients undergoing frozen–thawed embryo transfer: a 6-year population-based retrospective study. Arch Gynecol Obstet 300, 1083–1092 (2019). https://doi.org/10.1007/s00404-019-05298-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-019-05298-3

Keywords

Navigation